Beam Therapeutics Inc. — Director's Dealing 2021

Jun 17, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Verve Therapeutics, Inc. (VERV)
CIK: 0001840574
Period of Report: 2021-06-16

Reporting Person: Beam Therapeutics Inc. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	276075	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Stock	$		Common Stock (270895)		Direct

Footnotes

F1: Each share of the convertible preferred stock is convertible at any time, at the holder's election, into 0.108 shares of common stock, and will convert automatically upon the issuer's consummation of an initial public offering. The preferred stock has no expiration date.